P295: Absence of mucosal healing in patients undergoing assessment of mucosal healing with a normal PUCAI score in pediatric ulcerative colitisECCO '17 Barcelona
2017
P296: Persistent symptoms, CRP elevation and treatment changes over time in Crohn's disease patients are associated with bowel damage progression as expressed by deterioration of Lemann Index scoreECCO '17 Barcelona
2017
P297: Fecal calprotectin accurately predicts symptomatic relapse in children and adolescents with inflammatory bowel disease in clinical remissionECCO '17 Barcelona
2017
P298: Comparison between clinical and patient-reported symptoms among Crohn's disease and ulcerative colitis patientsECCO '17 Barcelona
2017
P299: Identification of a prognostic biomarker able to predict ulcerative colitis patients that will not respond to standard therapyECCO '17 Barcelona
2017
P300: Illness perceptions and coping with health-related quality of life in patients with inflammatory bowel diseaseECCO '17 Barcelona
2017
P301: Non-familial small bowel carcinomas in Crohn's disease: clinico-pathological, molecular and prognostic featuresECCO '17 Barcelona
2017
P302: Cytomegalovirus infection in pediatric acute severe ulcerative colitis – a multicenter case-controlled study from the Pediatric IBD Porto group of ESPGHANECCO '17 Barcelona
2017
P303: Gastrointestinal infectious agents detected by Biofire FilmArray GI PCR panel stool testing in active inflammatory bowel disease are common and associated with a more benign course of IBDECCO '17 Barcelona
2017
P304: Zinc levels, interplay with ATG16L1 and disease outcome in Crohn's disease patients in the Swiss IBD cohort studyECCO '17 Barcelona
2017
P305: Indirect comparison of two novel biologics for the treatment of Crohn's disease : network-meta analysis of ustekinumab vs vedolizumabECCO '17 Barcelona
2017
P306: What is the impact of perianal disease on anorectal function and quality of life of IBD patients? A prospective observational studyECCO '17 Barcelona
2017
P308: Safety of the given patency capsule in patients with Crohn's disease or suspected Crohn's diseaseECCO '17 Barcelona
2017
P309: Impact of rapid access MR on clinical decision making and patient management in Crohn's disease in a tertiary referral centerECCO '17 Barcelona
2017
P310: Development of a new clinico-biological score associated with disease activity in patients with inflammatory bowel disease treated with thiopurineECCO '17 Barcelona
2017
P311: Microscopic inflammation and myenteric plexitis at the margin of resection do not predict endoscopic recurrence in patients with Crohn's disease after ileocolic resectionECCO '17 Barcelona
2017